This content is from: Patents

UK Supreme Court wrestles with plausibility and the pregabalin patent

The UK Supreme Court last week heard argument in Warner Lambert v Generics. Pfizer argued that plausibility should be an "evidential tool" not a "threshold test", while Actavis warned against the danger of over-broad speculative claims and "armchair patenting”

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.

Related